These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1588 related items for PubMed ID: 19564034

  • 1. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K, Iwase T, Kita S, Watanabe Y.
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [Abstract] [Full Text] [Related]

  • 2. Fouling of reverse osmosis and nanofiltration membranes by dairy industry effluents.
    Turan M, Ates A, Inanc B.
    Water Sci Technol; 2002 Aug; 45(12):355-60. PubMed ID: 12201123
    [Abstract] [Full Text] [Related]

  • 3. Use of fouling resistant nanofiltration and reverse osmosis membranes for dyeing wastewater effluent treatment.
    Myung SW, Choi IH, Lee SH, Kim IC, Lee KH.
    Water Sci Technol; 2005 Aug; 51(6-7):159-64. PubMed ID: 16003974
    [Abstract] [Full Text] [Related]

  • 4. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD, Cho J, Kim IS, Vanderford BJ, Snyder SA.
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [Abstract] [Full Text] [Related]

  • 5. Can treated municipal wastewater be reused after ozonation and nanofiltration? Results from a pilot study of pharmaceutical removal in Henriksdal WWTP, Sweden.
    Flyborg L, Björlenius B, Persson KM.
    Water Sci Technol; 2010 Mar; 61(5):1113-20. PubMed ID: 20220232
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hospital wastewater effluent by nanofiltration and reverse osmosis.
    Beier S, Köster S, Veltmann K, Schröder H, Pinnekamp J.
    Water Sci Technol; 2010 Mar; 61(7):1691-8. PubMed ID: 20371926
    [Abstract] [Full Text] [Related]

  • 7. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, Peart T, Lee B, Servos M, Beland M, Seto P.
    Sci Total Environ; 2006 Aug 31; 367(2-3):544-58. PubMed ID: 16697441
    [Abstract] [Full Text] [Related]

  • 8. Viability of a low-pressure nanofilter in treating recycled water for water reuse applications: a pilot-scale study.
    Bellona C, Drewes JE.
    Water Res; 2007 Sep 31; 41(17):3948-58. PubMed ID: 17582458
    [Abstract] [Full Text] [Related]

  • 9. Fouling characteristics of NF and RO operated for removal of dissolved matter from groundwater.
    Gwon EM, Yu MJ, Oh HK, Ylee YH.
    Water Res; 2003 Jul 31; 37(12):2989-97. PubMed ID: 12767302
    [Abstract] [Full Text] [Related]

  • 10. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment.
    Radjenović J, Petrović M, Ventura F, Barceló D.
    Water Res; 2008 Aug 31; 42(14):3601-10. PubMed ID: 18656225
    [Abstract] [Full Text] [Related]

  • 11. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China.
    Sui Q, Huang J, Deng S, Yu G, Fan Q.
    Water Res; 2010 Jan 31; 44(2):417-26. PubMed ID: 19674764
    [Abstract] [Full Text] [Related]

  • 12. Combined coagulation-disk filtration process as a pretreatment of ultrafiltration and reverse osmosis membrane for wastewater reclamation: an autopsy study of a pilot plant.
    Chon K, Kim SJ, Moon J, Cho J.
    Water Res; 2012 Apr 15; 46(6):1803-16. PubMed ID: 22310806
    [Abstract] [Full Text] [Related]

  • 13. Distillery wastewater treatment by the membrane-based nanofiltration and reverse osmosis processes.
    Nataraj SK, Hosamani KM, Aminabhavi TM.
    Water Res; 2006 Jul 15; 40(12):2349-56. PubMed ID: 16757012
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MBR/RO/ozone processes for TFT-LCD industrial wastewater treatment and recycling.
    Chen TK, Ni CH, Chan YC, Lu MC.
    Water Sci Technol; 2005 Jul 15; 51(6-7):411-9. PubMed ID: 16004003
    [Abstract] [Full Text] [Related]

  • 16. Autopsy of high-pressure membranes to compare effectiveness of MF and UF pretreatment in water reclamation.
    Kim J, DiGiano FA, Reardon RD.
    Water Res; 2008 Feb 15; 42(3):697-706. PubMed ID: 17961627
    [Abstract] [Full Text] [Related]

  • 17. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J, Petrović M, Barceló D.
    Water Res; 2009 Feb 15; 43(3):831-41. PubMed ID: 19091371
    [Abstract] [Full Text] [Related]

  • 18. Removal of Pharmaceutical and Personal Care Products (PPCPs) from Municipal Waste Water with Integrated Membrane Systems, MBR-RO/NF.
    Wang Y, Wang X, Li M, Dong J, Sun C, Chen G.
    Int J Environ Res Public Health; 2018 Feb 05; 15(2):. PubMed ID: 29401723
    [Abstract] [Full Text] [Related]

  • 19. Ozone and biofiltration as an alternative to reverse osmosis for removing PPCPs and micropollutants from treated wastewater.
    Lee CO, Howe KJ, Thomson BM.
    Water Res; 2012 Mar 15; 46(4):1005-14. PubMed ID: 22202904
    [Abstract] [Full Text] [Related]

  • 20. Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan.
    Okuda T, Kobayashi Y, Nagao R, Yamashita N, Tanaka H, Tanaka S, Fujii S, Konishi C, Houwa I.
    Water Sci Technol; 2008 Mar 15; 57(1):65-71. PubMed ID: 18192742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.